Medical Journals

Timp-3 Deficiency in the Host, but Not in the Tumor, Enhances Tumor Growth and Angiogenesis.

Authors:
  • Cruz-Muñoz W
  • Kim I
  • Khokha R

From: Department of Laboratory Medicine and Pathobiology, Toronto, Ontario, Canada.

Oncogene

  • Publish Date: Jan 2006
  • ISSN: 0950-9232
  • Volume: 25
  • Issue: 4
  • Pages: 650-5
  • Medium: Print
  • Language: English
  • Citation (JAMA): Cruz-Muñoz W, Kim I, Khokha R, et al. Timp-3 Deficiency in the Host, but Not in the Tumor, Enhances Tumor Growth and Angiogenesis.. Oncogene Jan 2006;25:650-5

Abstract

Tumor cells, stromal cell compartment and the extracellular matrix (ECM) together generate a multifaceted tumor microenvironment. Matrix metalloproteinases and their tissue inhibitors (TIMPs) provide a means for tumor-stromal interaction during tumorigenesis. Among TIMPs, TIMP-3 is uniquely localized to the ECM and is frequently silenced in human cancers. Here, we asked whether the absence of TIMP-3 in the tumor cell or the host affects the process of tumorigenesis. Timp-3(-/-) ES-cell clones were generated and used to develop teratomas in nude mice. Timp-3(-/-) teratomas showed similar tumor take, growth, and angiogenesis compared to timp-3(+/+) teratomas. To study the effect of TIMP-3 ablation in the host stroma, we measured the growth kinetics of subcutaneous B16F10 melanomas in timp-3(-/-) and wild-type littermates. Tumors grew significantly faster in timp-3(-/-) than in wild-type mice and their CD31 content was significantly higher indicating increased angiogenesis. Augmented angiogenesis in timp-3(-/-) mice was directly tested using Matrigel plug and Gelfoam assays. In response to FGF-2, timp-3(-/-) endothelial cells invaded more efficiently, leading to enhanced formation of functional blood vessels. Thus, TIMP-3 deficiency in the host, but not in the tumor per se, leads to enhanced tumor growth and angiogenesis. TIMP-3 located within the tumor microenvironment inhibits tumorigenesis.

Mesh Headings (Keywords): Animals, Antigens, CD31, Matrix Metalloproteinase 2, Matrix Metalloproteinases, Matrix Metalloproteinases, Membrane-Associated, Melanoma, Experimental, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Nude, Neovascularization, Pathologic, Teratoma, Tissue Inhibitor of Metalloproteinase-3


Check for Full Text / PubMed Unique Identifier (PMID): 16186800


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.